 | • レポートコード：MR2211MG10772 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：医療 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、液体製剤用薬物送達のグローバル市場規模と予測を記載しています。・液体製剤用薬物送達のグローバル市場：売上、2017年-2022年、2023年-2028年 ・液体製剤用薬物送達のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 液体製剤用薬物送達のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「サスペンション」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 液体製剤用薬物送達のグローバル主要企業は、3M、 Merck & Co、 Crescita Therpeautics、 Novartis International、 Boehringer Ingelheim、 Pfizer、 Teva Pharmaceuticals、 Bristol Myers Squibb、 Lead Chemical、 Purdue Pharma、 Glenmark Pharmaceuticals、 Galderma、 Johnson & Johnson Private、 GlaxoSmithKline、 Bausch Health Companies、 Hisamitsu Pharmaceuticals、 Cipla、 Bayer、 Viatrisなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、液体製剤用薬物送達のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の液体製剤用薬物送達市場：タイプ別、2017年-2022年、2023年-2028年 世界の液体製剤用薬物送達市場：タイプ別市場シェア、2021年 ・サスペンション、溶液 世界の液体製剤用薬物送達市場：用途別、2017年-2022年、2023年-2028年 世界の液体製剤用薬物送達市場：用途別市場シェア、2021年 ・在宅医療施設、病院 & 診療所、やけどセンター、その他の施設 世界の液体製剤用薬物送達市場：地域・国別、2017年-2022年、2023年-2028年 世界の液体製剤用薬物送達市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における液体製剤用薬物送達のグローバル売上、2017年-2022年 ・主要企業における液体製剤用薬物送達のグローバル売上シェア、2021年 ・主要企業における液体製剤用薬物送達のグローバル販売量、2017年-2022年 ・主要企業における液体製剤用薬物送達のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 3M、 Merck & Co、 Crescita Therpeautics、 Novartis International、 Boehringer Ingelheim、 Pfizer、 Teva Pharmaceuticals、 Bristol Myers Squibb、 Lead Chemical、 Purdue Pharma、 Glenmark Pharmaceuticals、 Galderma、 Johnson & Johnson Private、 GlaxoSmithKline、 Bausch Health Companies、 Hisamitsu Pharmaceuticals、 Cipla、 Bayer、 Viatris ************************************************************* ・調査・分析レポートの概要 液体製剤用薬物送達市場の定義 市場セグメント 世界の液体製剤用薬物送達市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の液体製剤用薬物送達市場規模 世界の液体製剤用薬物送達市場規模：2021年 VS 2028年 世界の液体製剤用薬物送達市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの液体製剤用薬物送達の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の液体製剤用薬物送達製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：サスペンション、溶液 液体製剤用薬物送達のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：在宅医療施設、病院 & 診療所、やけどセンター、その他の施設 液体製剤用薬物送達の用途別グローバル売上・予測 ・地域別市場分析 地域別液体製剤用薬物送達市場規模 2021年と2028年 地域別液体製剤用薬物送達売上・予測 北米市場 - アメリカの液体製剤用薬物送達市場規模2017年-2028年 - カナダの液体製剤用薬物送達市場規模2017年-2028年 - メキシコの液体製剤用薬物送達市場規模2017年-2028年 ヨーロッパ市場 - ドイツの液体製剤用薬物送達市場規模2017年-2028年 - フランスの液体製剤用薬物送達市場規模2017年-2028年 - イギリスの液体製剤用薬物送達市場規模2017年-2028年 - イタリアの液体製剤用薬物送達市場規模2017年-2028年 - ロシアの液体製剤用薬物送達市場規模2017年-2028年 アジア市場 - 中国の液体製剤用薬物送達市場規模2017年-2028年 - 日本の液体製剤用薬物送達市場規模2017年-2028年 - 韓国の液体製剤用薬物送達市場規模2017年-2028年 - 東南アジアの液体製剤用薬物送達市場規模2017年-2028年 - インドの液体製剤用薬物送達市場規模2017年-2028年 南米市場 - ブラジルの液体製剤用薬物送達市場規模2017年-2028年 - アルゼンチンの液体製剤用薬物送達市場規模2017年-2028年 中東・アフリカ市場 - トルコの液体製剤用薬物送達市場規模2017年-2028年 - イスラエルの液体製剤用薬物送達市場規模2017年-2028年 - サウジアラビアの液体製剤用薬物送達市場規模2017年-2028年 - UAEの液体製剤用薬物送達市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） 3M、 Merck & Co、 Crescita Therpeautics、 Novartis International、 Boehringer Ingelheim、 Pfizer、 Teva Pharmaceuticals、 Bristol Myers Squibb、 Lead Chemical、 Purdue Pharma、 Glenmark Pharmaceuticals、 Galderma、 Johnson & Johnson Private、 GlaxoSmithKline、 Bausch Health Companies、 Hisamitsu Pharmaceuticals、 Cipla、 Bayer、 Viatris ... |
Suspensions are defined as finely divided undissolved drugs dispersed in liquid vehicles. They can be a ready-to-use liquid suspension or a dry powder reconstitutable suspension, which is dispersed in water by the patient, a caregiver or a pharmacist. Solutions are defined as liquid preparations in which the drug and the various excipients are dissolved in the suitable solvent or aqueous system.
This report contains market size and forecasts of Liquid Formulations Drug Delivery in Global, including the following market information:
Global Liquid Formulations Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Liquid Formulations Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Suspensions Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Liquid Formulations Drug Delivery include 3M, Merck & Co, Crescita Therpeautics, Novartis International, Boehringer Ingelheim, Pfizer, Teva Pharmaceuticals, Bristol Myers Squibb and Lead Chemical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liquid Formulations Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liquid Formulations Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Liquid Formulations Drug Delivery Market Segment Percentages, by Type, 2021 (%)
Suspensions
Solutions
Global Liquid Formulations Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Liquid Formulations Drug Delivery Market Segment Percentages, by Application, 2021 (%)
Home Care Settings
Hospitals & Clinics
Burn Centers
Other Facilities
Global Liquid Formulations Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Liquid Formulations Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liquid Formulations Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Liquid Formulations Drug Delivery revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Merck & Co
Crescita Therpeautics
Novartis International
Boehringer Ingelheim
Pfizer
Teva Pharmaceuticals
Bristol Myers Squibb
Lead Chemical
Purdue Pharma
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline
Bausch Health Companies
Hisamitsu Pharmaceuticals
Cipla
Bayer
Viatris
1 Introduction to Research & Analysis Reports
1.1 Liquid Formulations Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liquid Formulations Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liquid Formulations Drug Delivery Overall Market Size
2.1 Global Liquid Formulations Drug Delivery Market Size: 2021 VS 2028
2.2 Global Liquid Formulations Drug Delivery Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Liquid Formulations Drug Delivery Players in Global Market
3.2 Top Global Liquid Formulations Drug Delivery Companies Ranked by Revenue
3.3 Global Liquid Formulations Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Liquid Formulations Drug Delivery Companies in Global Market, by Revenue in 2021
3.5 Global Companies Liquid Formulations Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liquid Formulations Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Liquid Formulations Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Liquid Formulations Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Liquid Formulations Drug Delivery Market Size Markets, 2021 & 2028
4.1.2 Suspensions
4.1.3 Solutions
4.2 By Type – Global Liquid Formulations Drug Delivery Revenue & Forecasts
4.2.1 By Type – Global Liquid Formulations Drug Delivery Revenue, 2017-2022
4.2.2 By Type – Global Liquid Formulations Drug Delivery Revenue, 2023-2028
4.2.3 By Type – Global Liquid Formulations Drug Delivery Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Liquid Formulations Drug Delivery Market Size, 2021 & 2028
5.1.2 Home Care Settings
5.1.3 Hospitals & Clinics
5.1.4 Burn Centers
5.1.5 Other Facilities
5.2 By Application – Global Liquid Formulations Drug Delivery Revenue & Forecasts
5.2.1 By Application – Global Liquid Formulations Drug Delivery Revenue, 2017-2022
5.2.2 By Application – Global Liquid Formulations Drug Delivery Revenue, 2023-2028
5.2.3 By Application – Global Liquid Formulations Drug Delivery Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Liquid Formulations Drug Delivery Market Size, 2021 & 2028
6.2 By Region – Global Liquid Formulations Drug Delivery Revenue & Forecasts
6.2.1 By Region – Global Liquid Formulations Drug Delivery Revenue, 2017-2022
6.2.2 By Region – Global Liquid Formulations Drug Delivery Revenue, 2023-2028
6.2.3 By Region – Global Liquid Formulations Drug Delivery Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Liquid Formulations Drug Delivery Revenue, 2017-2028
6.3.2 US Liquid Formulations Drug Delivery Market Size, 2017-2028
6.3.3 Canada Liquid Formulations Drug Delivery Market Size, 2017-2028
6.3.4 Mexico Liquid Formulations Drug Delivery Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Liquid Formulations Drug Delivery Revenue, 2017-2028
6.4.2 Germany Liquid Formulations Drug Delivery Market Size, 2017-2028
6.4.3 France Liquid Formulations Drug Delivery Market Size, 2017-2028
6.4.4 U.K. Liquid Formulations Drug Delivery Market Size, 2017-2028
6.4.5 Italy Liquid Formulations Drug Delivery Market Size, 2017-2028
6.4.6 Russia Liquid Formulations Drug Delivery Market Size, 2017-2028
6.4.7 Nordic Countries Liquid Formulations Drug Delivery Market Size, 2017-2028
6.4.8 Benelux Liquid Formulations Drug Delivery Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Liquid Formulations Drug Delivery Revenue, 2017-2028
6.5.2 China Liquid Formulations Drug Delivery Market Size, 2017-2028
6.5.3 Japan Liquid Formulations Drug Delivery Market Size, 2017-2028
6.5.4 South Korea Liquid Formulations Drug Delivery Market Size, 2017-2028
6.5.5 Southeast Asia Liquid Formulations Drug Delivery Market Size, 2017-2028
6.5.6 India Liquid Formulations Drug Delivery Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Liquid Formulations Drug Delivery Revenue, 2017-2028
6.6.2 Brazil Liquid Formulations Drug Delivery Market Size, 2017-2028
6.6.3 Argentina Liquid Formulations Drug Delivery Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Liquid Formulations Drug Delivery Revenue, 2017-2028
6.7.2 Turkey Liquid Formulations Drug Delivery Market Size, 2017-2028
6.7.3 Israel Liquid Formulations Drug Delivery Market Size, 2017-2028
6.7.4 Saudi Arabia Liquid Formulations Drug Delivery Market Size, 2017-2028
6.7.5 UAE Liquid Formulations Drug Delivery Market Size, 2017-2028
7 Players Profiles
7.1 3M
7.1.1 3M Corporate Summary
7.1.2 3M Business Overview
7.1.3 3M Liquid Formulations Drug Delivery Major Product Offerings
7.1.4 3M Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.1.5 3M Key News
7.2 Merck & Co
7.2.1 Merck & Co Corporate Summary
7.2.2 Merck & Co Business Overview
7.2.3 Merck & Co Liquid Formulations Drug Delivery Major Product Offerings
7.2.4 Merck & Co Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.2.5 Merck & Co Key News
7.3 Crescita Therpeautics
7.3.1 Crescita Therpeautics Corporate Summary
7.3.2 Crescita Therpeautics Business Overview
7.3.3 Crescita Therpeautics Liquid Formulations Drug Delivery Major Product Offerings
7.3.4 Crescita Therpeautics Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.3.5 Crescita Therpeautics Key News
7.4 Novartis International
7.4.1 Novartis International Corporate Summary
7.4.2 Novartis International Business Overview
7.4.3 Novartis International Liquid Formulations Drug Delivery Major Product Offerings
7.4.4 Novartis International Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.4.5 Novartis International Key News
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Corporate Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Liquid Formulations Drug Delivery Major Product Offerings
7.5.4 Boehringer Ingelheim Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.5.5 Boehringer Ingelheim Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Liquid Formulations Drug Delivery Major Product Offerings
7.6.4 Pfizer Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.6.5 Pfizer Key News
7.7 Teva Pharmaceuticals
7.7.1 Teva Pharmaceuticals Corporate Summary
7.7.2 Teva Pharmaceuticals Business Overview
7.7.3 Teva Pharmaceuticals Liquid Formulations Drug Delivery Major Product Offerings
7.7.4 Teva Pharmaceuticals Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.7.5 Teva Pharmaceuticals Key News
7.8 Bristol Myers Squibb
7.8.1 Bristol Myers Squibb Corporate Summary
7.8.2 Bristol Myers Squibb Business Overview
7.8.3 Bristol Myers Squibb Liquid Formulations Drug Delivery Major Product Offerings
7.8.4 Bristol Myers Squibb Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.8.5 Bristol Myers Squibb Key News
7.9 Lead Chemical
7.9.1 Lead Chemical Corporate Summary
7.9.2 Lead Chemical Business Overview
7.9.3 Lead Chemical Liquid Formulations Drug Delivery Major Product Offerings
7.9.4 Lead Chemical Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.9.5 Lead Chemical Key News
7.10 Purdue Pharma
7.10.1 Purdue Pharma Corporate Summary
7.10.2 Purdue Pharma Business Overview
7.10.3 Purdue Pharma Liquid Formulations Drug Delivery Major Product Offerings
7.10.4 Purdue Pharma Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.10.5 Purdue Pharma Key News
7.11 Glenmark Pharmaceuticals
7.11.1 Glenmark Pharmaceuticals Corporate Summary
7.11.2 Glenmark Pharmaceuticals Business Overview
7.11.3 Glenmark Pharmaceuticals Liquid Formulations Drug Delivery Major Product Offerings
7.11.4 Glenmark Pharmaceuticals Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.11.5 Glenmark Pharmaceuticals Key News
7.12 Galderma
7.12.1 Galderma Corporate Summary
7.12.2 Galderma Business Overview
7.12.3 Galderma Liquid Formulations Drug Delivery Major Product Offerings
7.12.4 Galderma Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.12.5 Galderma Key News
7.13 Johnson & Johnson Private
7.13.1 Johnson & Johnson Private Corporate Summary
7.13.2 Johnson & Johnson Private Business Overview
7.13.3 Johnson & Johnson Private Liquid Formulations Drug Delivery Major Product Offerings
7.13.4 Johnson & Johnson Private Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.13.5 Johnson & Johnson Private Key News
7.14 GlaxoSmithKline
7.14.1 GlaxoSmithKline Corporate Summary
7.14.2 GlaxoSmithKline Business Overview
7.14.3 GlaxoSmithKline Liquid Formulations Drug Delivery Major Product Offerings
7.14.4 GlaxoSmithKline Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.14.5 GlaxoSmithKline Key News
7.15 Bausch Health Companies
7.15.1 Bausch Health Companies Corporate Summary
7.15.2 Bausch Health Companies Business Overview
7.15.3 Bausch Health Companies Liquid Formulations Drug Delivery Major Product Offerings
7.15.4 Bausch Health Companies Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.15.5 Bausch Health Companies Key News
7.16 Hisamitsu Pharmaceuticals
7.16.1 Hisamitsu Pharmaceuticals Corporate Summary
7.16.2 Hisamitsu Pharmaceuticals Business Overview
7.16.3 Hisamitsu Pharmaceuticals Liquid Formulations Drug Delivery Major Product Offerings
7.16.4 Hisamitsu Pharmaceuticals Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.16.5 Hisamitsu Pharmaceuticals Key News
7.17 Cipla
7.17.1 Cipla Corporate Summary
7.17.2 Cipla Business Overview
7.17.3 Cipla Liquid Formulations Drug Delivery Major Product Offerings
7.17.4 Cipla Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.17.5 Cipla Key News
7.18 Bayer
7.18.1 Bayer Corporate Summary
7.18.2 Bayer Business Overview
7.18.3 Bayer Liquid Formulations Drug Delivery Major Product Offerings
7.18.4 Bayer Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.18.5 Bayer Key News
7.19 Viatris
7.19.1 Viatris Corporate Summary
7.19.2 Viatris Business Overview
7.19.3 Viatris Liquid Formulations Drug Delivery Major Product Offerings
7.19.4 Viatris Liquid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.19.5 Viatris Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer